Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
1-15 of 622
Examining the Link Between Surgical Menopause and Heart Failure
Heart MattersExamining the Link Between Surgical Menopause and Heart Failure
Elise Shalowitz, MS
Precision Medicine in Fibrotic ILD: Predicting Risk and Treatment Response
Clinician's RoundtablePrecision Medicine in Fibrotic ILD: Predicting Risk and Treatment Response
Pilar Rivera-Ortega, MD
Recognizing Telomere Biology Disorders in Familial Pulmonary Fibrosis
Clinician's RoundtableRecognizing Telomere Biology Disorders in Familial Pulmonary Fibrosis
Pilar Rivera-Ortega, MD
Targeting Pseudomonas aeruginosa in Bronchiectasis: Phase 2a Findings
Clinician's RoundtableTargeting Pseudomonas aeruginosa in Bronchiectasis: Phase 2a Findings
Colm Leonard, MD
Tobacco-Related Stigma as a Barrier to Lung Cancer Screening
Project Oncology®Tobacco-Related Stigma as a Barrier to Lung Cancer Screening
Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM
A Patient-First Approach to Smoking Cessation and Lung Cancer Screening
Project Oncology®A Patient-First Approach to Smoking Cessation and Lung Cancer Screening
Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM
- advertisement
Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
Heart MattersSubcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
M. Melih Dogan, MD
Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Project Oncology®Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Jonathon B. Cohen, MD, MS
Supportive Care During and After CLL Treatment: What to Prioritize
Project Oncology®Supportive Care During and After CLL Treatment: What to Prioritize
Kerry A. Rogers, MD
How Myeloid Mutations in ALL Inform Treatment Decisions
Project Oncology®How Myeloid Mutations in ALL Inform Treatment Decisions
Caner Saygin, MD
Moving Beyond Chemotherapy in Mantle Cell Lymphoma Care
Project Oncology®Moving Beyond Chemotherapy in Mantle Cell Lymphoma Care
Jonathon Cohen, MD, MS
Myeloid Mutations in ALL: Disease Risk and Prognostic Implications
Project Oncology®Myeloid Mutations in ALL: Disease Risk and Prognostic Implications
Caner Saygin, MD
- advertisement
Adapting CV Risk Reduction Strategies for Cancer Survivorship
Heart MattersAdapting CV Risk Reduction Strategies for Cancer Survivorship
Stephanie Dixon, MD, MPH
Supportive Care Before CLL Treatment: Infection Risk and Comorbidity Management
Project Oncology®Supportive Care Before CLL Treatment: Infection Risk and Comorbidity Management
Kerry A. Rogers, MD
A Long-Term View of Cardiovascular Risk After Cancer Treatment
Heart MattersA Long-Term View of Cardiovascular Risk After Cancer Treatment
Stephanie Dixon, MD, MPH
